🔗 Visit the ClinicalTrials.gov page for NCT02433626
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). | Eur J Cancer | 2009 | 77.71 |
| 2 | Integrated genomic analyses of ovarian carcinoma. | Nature | 2011 | 47.72 |
| 3 | Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. | Cancer Res | 2006 | 17.42 |
| 4 | Mutational landscape and significance across 12 major cancer types. | Nature | 2013 | 14.91 |
| 5 | Mutant p53: one name, many proteins. | Genes Dev | 2012 | 4.33 |
| 6 | Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. | Int J Gynaecol Obstet | 2006 | 3.25 |
| 7 | Chemotherapy for recurrent, metastatic, or persistent cervical cancer: a systematic review. | Int J Gynecol Cancer | 2007 | 0.98 |
| 8 | Systemic therapy for recurrent endometrial cancer: a review of North American trials. | Expert Rev Anticancer Ther | 2009 | 0.96 |
| 9 | Management of the late effects of treatments for gynecological cancer. | Curr Opin Oncol | 2013 | 0.77 |